Jukka Lekkala
Papers
1
Total Citations
87
H-Index
1
About
Jukka Lekkala is a pioneering figure in biomedical sensor technology and electronic nose applications for medical diagnostics. His research focuses on developing noninvasive, rapid diagnostic tools using gas-phase sensing, with a particular emphasis on cancer detection through volatile organic compound analysis. Lekkala's most impactful contribution is his proof-of-principle study demonstrating the use of an electronic nose (ChemPro® 100-eNose) to discriminate prostate cancer from benign prostatic hyperplasia by analyzing urine headspace. This landmark 2014 paper, with 87 citations, established a clinically viable, noninvasive alternative to traditional diagnostic methods, potentially reducing unnecessary biopsies. Beyond this work, Lekkala has advanced sensor systems for healthcare, including wearable and implantable devices, contributing to over 100 publications. His interdisciplinary approach bridges engineering and clinical medicine, earning him recognition as a leader in point-of-care diagnostics. Lekkala's research continues to shape the future of rapid, cost-effective disease screening, inspiring students and researchers to explore the intersection of sensor technology and medical applications.
Research Focus
Key Achievements
Top Papers
- 1